A Study of DS-8201a in Metastatic Breast Cancer Previously Treated With Trastuzumab Emtansine (T-DM1)

NCT03248492 · clinicaltrials.gov ↗

PHASE2

Phase

TERMINATED

Status

253

Enrollment

INDUSTRY

Sponsor class

Stopped The last participant was transitioned to alternative study.

Conditions

Breast Cancer

Interventions

DRUG: DS-8201a

Sponsor

Daiichi Sankyo

Collaborators

[object Object]
[object Object]